BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36253663)

  • 1. [
    de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
    Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Diagnostics and [
    de Koster EJ; Morreau H; Bleumink GS; van Engen-van Grunsven ACH; de Geus-Oei LF; Links TP; Wakelkamp IMMJ; Oyen WJG; Vriens D
    Thyroid; 2024 Jan; 34(1):41-53. PubMed ID: 38009209
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative classification and radiomics of [
    de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced modulation of glucose transporter expression impacts
    Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    de Koster EJ; de Geus-Oei LF; Brouwers AH; van Dam EWCM; Dijkhorst-Oei LT; van Engen-van Grunsven ACH; van den Hout WB; Klooker TK; Netea-Maier RT; Snel M; Oyen WJG; Vriens D;
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1970-1984. PubMed ID: 34981165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in incidentally detected thyroid cancer.
    Kim BH; Kim IJ; Kim SS; Kim SJ; Lee CH; Kim YK
    Cancer Biother Radiopharm; 2010 Jun; 25(3):309-15. PubMed ID: 20578836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
    Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
    World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
    Yoon M; Jung SJ; Kim TH; Ha TK; Urm SH; Park JS; Lee SM; Bae SK
    Endocr Res; 2016; 41(1):64-9. PubMed ID: 26513490
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
    Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
    Deandreis D; Al Ghuzlan A; Auperin A; Vielh P; Caillou B; Chami L; Lumbroso J; Travagli JP; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2012 Feb; 22(2):165-72. PubMed ID: 22257371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography.
    Park SI; Suh DS; Kim SJ; Choi KU; Yoon MS
    Onkologie; 2013; 36(4):169-74. PubMed ID: 23548964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
    World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT1 expression in high-risk prostate cancer: correlation with
    Meziou S; Ringuette Goulet C; Hovington H; Lefebvre V; Lavallée É; Bergeron M; Brisson H; Champagne A; Neveu B; Lacombe D; Beauregard JM; Buteau FA; Riopel J; Pouliot F
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):441-448. PubMed ID: 31932660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound stratification of the FDG-avid thyroid nodule.
    Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
    Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated
    Li-Ou Z; Hong-Zan S; Xiao-Xi B; Zhong-Wei C; Zai-Ming L; Jun X; Qi-Yong G
    J Magn Reson Imaging; 2019 Jun; 49(6):1704-1712. PubMed ID: 30390401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can dynamic imaging, using
    Marin A; Murchison JT; Skwarski KM; Tavares AAS; Fletcher A; Wallace WA; Salapura V; van Beek EJR; Mirsadraee S
    Radiol Oncol; 2021 May; 55(3):259-267. PubMed ID: 34051709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.